| Country | Shipping method | Delivery time | Price | |
|
|
Delivery |
14-21 days | 10$ | Tracking# available in 4 days |
Delivery |
9-14 days | 30$ | Tracking# available in 2 days |
Invokana (canagliflozin) is a prescription medication used to treat type 2 diabetes mellitus. As a sodium‑glucose co‑transporter 2 (SGLT2) inhibitor, it reduces glucose reabsorption in the kidneys, promotes urinary glucose excretion, and helps lower blood sugar levels.
Typical dosing: one tablet daily before the first meal of the day. Swallow the tablet whole with water; do not crush or chew. The dose may be adjusted based on kidney function, concomitant medications, and patient response. Regular monitoring of blood glucose is recommended.
Take one tablet daily before breakfast.
Do not crush or chew the tablet.
Adjust dosage according to kidney function and other medications.
Check blood sugar levels regularly.
Before starting Invokana, inform your healthcare provider if you have kidney disease, liver disease, low blood pressure, a history of urinary tract infections, or a history of ketoacidosis. Maintain adequate hydration and watch for signs of dehydration or urinary infection.
Notify doctor of kidney or liver conditions.
Avoid use if you have a history of urinary tract infections.
Maintain proper fluid intake.
Monitor for dehydration or infection signs.
Do not use Invokana if you are allergic to canagliflozin or any tablet component. It is contraindicated in patients with severe kidney impairment or end‑stage renal disease, and it should be avoided during pregnancy or breastfeeding unless a healthcare professional advises otherwise.
Avoid if allergic to canagliflozin.
Not for severe kidney disease or end‑stage renal disease.
Use with caution during pregnancy and breastfeeding.
Common side effects include urinary tract infections, genital yeast infections, increased urination, thirst, and constipation. Serious side effects may include ketoacidosis, kidney injury, low blood pressure, or severe infections. Seek immediate medical attention if severe symptoms occur.
Urinary tract infections
Genital yeast infections
Increased urination and thirst
Constipation
Ketoacidosis (serious)
Kidney injury
Low blood pressure
Severe infections
Invokana may interact with diuretics, blood pressure medications, insulin, and other antidiabetic drugs. Provide a complete list of prescription medicines, over‑the‑counter products, and supplements to your healthcare provider.
Potential interactions with diuretics.
Interactions with blood pressure lowering agents.
Possible effects with insulin and other antidiabetic medications.
Inform provider of all medications and supplements.
If you miss a dose, take it as soon as you remember unless it is almost time for the next scheduled dose. Do not double the dose to catch up.
Overdose may cause dehydration, severely low blood sugar, or kidney problems. Seek immediate medical attention if an overdose is suspected.
Store Invokana at room temperature, away from heat, moisture, and light. Keep tablets in the original container and out of reach of children.
This information provides general guidance about Invokana (canagliflozin) and does not replace professional medical advice. Dosage, treatment plans, and precautions should be discussed with a qualified healthcare provider. The site disclaims any liability for errors or misuse of this information.